The field of central nervous system (CNS) inflammatory demyelinating diseases (IDD) has undergone considerable change with the discovery of antibodies against the aquaporin-4 water channel (AQP4-Ab) in neuromyelitis optica spectrum disorders (NMOSD) [30, 31]. This evidence concerns the gene AQP4 and neuromyelitis optica.